These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypothalamic-pituitary-adrenocortical axis activity as a potential predictor for withdrawal symptoms in addiction to flupirtine, a nonopiate analgesic. Hennings JM; Ising M; Klengel T; Knop M; Rosenhagen MC J Clin Psychopharmacol; 2014 Dec; 34(6):e6-8. PubMed ID: 24633005 [No Abstract] [Full Text] [Related]
6. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review. Jakuszkowiak-Wojten K; Landowski J; Wiglusz MS; Cubała WJ Psychiatr Danub; 2015 Sep; 27 Suppl 1():S445-51. PubMed ID: 26417813 [TBL] [Abstract][Full Text] [Related]
7. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. Jokinen J; Nordström P J Affect Disord; 2009 Jul; 116(1-2):88-92. PubMed ID: 19054568 [TBL] [Abstract][Full Text] [Related]
8. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies]. Vollenweider P; Waeber G Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472 [TBL] [Abstract][Full Text] [Related]
9. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633 [TBL] [Abstract][Full Text] [Related]
10. Drug dependence: stress and dysregulation of brain reward pathways. Kreek MJ; Koob GF Drug Alcohol Depend; 1998; 51(1-2):23-47. PubMed ID: 9716928 [No Abstract] [Full Text] [Related]
11. The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock. Williamson DR; Lapointe M Pharmacotherapy; 2003 Apr; 23(4):514-25. PubMed ID: 12680481 [TBL] [Abstract][Full Text] [Related]
12. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR). Navarro-Zaragoza J; Laorden ML; Milanés MV Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750 [TBL] [Abstract][Full Text] [Related]
13. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases. Huber BM; Bolt IB; Sauvain MJ; Flück CE Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769 [TBL] [Abstract][Full Text] [Related]
14. Suppression of the HPA axis in pediatric patients with atopic dermatitis. Ishay A; Ziv M; Kerner M; Luboshitzky R Arch Dermatol; 2007 Nov; 143(11):1449-50. PubMed ID: 18025377 [No Abstract] [Full Text] [Related]
15. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal]. Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139 [TBL] [Abstract][Full Text] [Related]
16. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal. Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718 [TBL] [Abstract][Full Text] [Related]
18. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Armario A Trends Pharmacol Sci; 2010 Jul; 31(7):318-25. PubMed ID: 20537734 [TBL] [Abstract][Full Text] [Related]
19. Endocrine disorders in pregnancy: stress responses in children after maternal glucocorticoids. Challis JR Nat Rev Endocrinol; 2012 Nov; 8(11):629-30. PubMed ID: 23032175 [No Abstract] [Full Text] [Related]
20. Joint synchrony of reciprocal hormonal signaling in human paradigms of both ACTH excess and cortisol depletion. Liu PY; Pincus SM; Keenan DM; Roelfsema F; Veldhuis JD Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E160-5. PubMed ID: 15727954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]